CRP /Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients

StatusUnknown
PhaseNot specified
Started

Record status This record was last updated December 27, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assiut University
1,667 trials monitored
See 15 trials at risk
This study aimed to assess the clinical utility of the NLR (neutrophil lymphocyte ratio) and CRP Albumin ratio in predicting activity of IBD Patients in assiut university
Trial Details
NCT Number NCT06750315
Lead Sponsor Assiut University
Conditions
(from sponsor)		 Inflammatory Bowel Disease (IBD)
Related terms Inflammatory Bowel Diseases
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov